Quality of life should be the primary outcome for disease modifying therapy trials in MS—No

Research output: Contribution to journal › Comment/Letter to the editor › Academic

2 Citations (Scopus)

Access to Document

@article{83724aaadac544f79374fc3995e6651a,

title = "Quality of life should be the primary outcome for disease modifying therapy trials in MS—No",

author = "Strijbis, {E. M. M.} and Koch, {M. W.} and {de Jong}, {B. A.}",

year = "2023",

month = aug,

doi = "https://doi.org/10.1177/13524585231182708",

language = "English",

volume = "29",

pages = "1066--1067",

journal = "MULTIPLE SCLEROSIS JOURNAL",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "9",

}

TY - JOUR

T1 - Quality of life should be the primary outcome for disease modifying therapy trials in MS—No

AU - Strijbis, E. M. M.

AU - Koch, M. W.

AU - de Jong, B. A.

PY - 2023/8

Y1 - 2023/8

UR - http://www.scopus.com/inward/record.url?scp=85165886701&partnerID=8YFLogxK

U2 - https://doi.org/10.1177/13524585231182708

DO - https://doi.org/10.1177/13524585231182708

M3 - Comment/Letter to the editor

C2 - 37489564

SN - 1352-4585

VL - 29

SP - 1066

EP - 1067

JO - MULTIPLE SCLEROSIS JOURNAL

JF - MULTIPLE SCLEROSIS JOURNAL

IS - 9

ER -